【24h】

Argon plasma surgery for the inferior turbinate of patients with perennial nasal allergy.

机译:氩等离子体手术用于常年性鼻过敏患者的下鼻甲。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Argon plasma coagulation (APC) is a new electrosurgical modality. The advantages of APC are coagulating of the target tissue without contact and the creation of uniformly deep devitalized and coagulated zones. The objectives of the present study were to determine the clinical effects of APC for the inferior turbinate of patients with nasal allergy and to clarify the histological changes in the mucosa after APC. STUDY DESIGN: In a prospective study, 95 patients with perennial nasal allergy were treated with APC. Nasal symptoms and intranasal findings were evaluated preoperatively and 1, 3, and 6 months, and 1 year after the APC. Mucosal specimens from the turbinates were examined under light and electron microscopy. RESULTS: Nasal stuffiness was improved in 77 of 79 (97.5%) patients after 1 month, in 50 of 51 (98.0%) patients after 3 months, in 20 of 23 (87.0%) patients after 6 months, and in 9 of 12 (75.0%) patients at 1 year after the APC. Rhinorrhea was improved in 46 of 75 (61.3%) patients after 1 month, in 40 of 51 (78.4%) patients after 3 months, in 16 of 21 (76.2%) patients after 6 months, and in 6 of 10 (60.0%) patients at 1 year after the APC. The sneezing was improved in 32 of 54 (59.3%) patients after 1 month, in 21 of 35 (60.0%) patients after 3 months, in 10 of 14 (71.4%) patients after 6 months, and in 6 of 8 (75.0%) patients at 1 year after the APC. In the intranasal findings, congestion of the inferior turbinate improved in 75 of 76 (98.7%) patients after 1 month, in 49 of 52 (94.2%) patients after 3 months, in 20 of 23 (87.0%) patients after 6 months, and in 7 of 11 (63.6%) patients at 1 year after the APC. The nasal discharge was reduced in 40 of 75 (53.3%) patients after 1 month, in 32 of 52 (61.5%) patients after 3 months, in 15 of 22 (68.2%) patients after 6 months, and in 5 of 11 (45.5%) patients at 1 year after the APC. No patients needed nasal packing after the APC. CONCLUSIONS: This is the first report on the clinical effects of turbinate surgery for nasal allergy using APC. APC was useful fer turbinate surgery of nasal allergy, especially for nasal stuffiness and congestion of the turbinate.
机译:目的:氩等离子体凝结(APC)是一种新型的电外科手术形式。 APC的优点是可以在不接触的情况下凝结靶组织,并可以形成深度均匀的失活和凝结区域。本研究的目的是确定APC对鼻过敏患者下鼻甲的临床疗效,并阐明APC后黏膜的组织学变化。研究设计:在一项前瞻性研究中,对95名常年性鼻过敏患者进行了APC治疗。术前,APC后1、3、6个月和1年评估鼻部症状和鼻内发现。在光学和电子显微镜下检查了鼻甲的粘膜标本。结果:1个月后,有79例患者中的77例(97.5%)改善了鼻闷,3个月后有51例患者中的50例(98.0%)改善了鼻息,6个月后有23例患者中的20例(87.0%)和12例中的9例得到了改善(75.0%)APC后1年的患者。 1个月后的75例患者中有46例(61.3%)鼻漏得到改善; 3个月后的51例中有40例(78.4%)的鼻漏得到了改善; 6个月后的21例中有16例(76.2%)的患者出现了鼻漏; 10例中的6例(60.0%) )APC后1年的患者。 1个月后54例患者中有32例(59.3%)的喷嚏得到改善,3个月后35例中21例(60.0%)的患者喷嚏得到改善,6个月后14例中有10例(71.4%)的患者打喷嚏,8例中有6例(75.0) %)APC后1年的患者。在鼻内发现中,下鼻甲充血在1个月后改善了76名患者中的75名(98.7%),3个月后改善了52名患者中的49名(94.2%),6个月之后改善了23名患者中的20名(87.0%),在APC术后1年中,有11名患者中有7名(63.6%)。 1个月后,有75名患者中的40名(53.3%)的鼻涕减少; 3个月后,有52名患者中的32名(61.5%)的鼻涕减少; 6个月后,有22名患者中的15名(68.2%)的鼻涕减少了(11名中的5名)( APC 1年后有45.5%)患者。 APC后没有患者需要鼻腔填充。结论:这是关于使用APC进行鼻甲手术对鼻过敏的临床效果的第一篇报道。 APC对鼻过敏的鼻甲外科手术很有用,特别是对于鼻塞和鼻甲充血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号